Dr. Hira I. Cheema, MD

Dr. Cheema practices at UAMS Medical Center in Little Rock, Arkansas, part of University of Arkansas for Medical Sciences.

Dr. Cheema's NPI, 1609258938, was assigned on June 23, 2015. Dr. Cheema holds Arkansas license E-11608.

Dr. Cheema's primary practice is UAMS Medical Center, at 4301 West Markham Street Mail Slot 612, Little Rock, AR 72205 in Pulaski County. The practice phone is (501) 686-5000.

Dr. Cheema's primary practice is UAMS Medical Center in Little Rock, Arkansas, part of University of Arkansas for Medical Sciences. Dr. Cheema is also affiliated with Baptist Health Medical Center-Conway. The medical group on file is UAMS - University of Arkansas for Medical Sciences. Dmand AI also links Dr. Cheema to 3 more hospitals and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cheema practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Cheema's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Cheema is licensed in Arkansas.

CMS data shows 884 Medicare services from Dr. Cheema across 6 procedure codes in 2024, for 313 Medicare patients. Medicare paid $66,910 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 313 Medicare patients who saw Dr. Cheema in 2024. The largest group is 65 to 74, with 116 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cheema's median patient age at 70, with 54% women.

In 2024, Dr. Cheema wrote 367 Medicare Part D claims for 116 patients. 86% of them were for generic drugs. CMS names the drug for 147 of them, across 9 drugs with 11 or more claims each, at $14,951 in total drug cost. In 2023, CMS named 227 claims across 11 drugs.

Dr. Cheema accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 10 papers to Dr. Cheema, published from 2017 to 2024. 2022 was the busiest year, with 5. Dr. Cheema has published most often in Cureus. Dr. Cheema's most frequent co-authors are Benjamin Tharian, MD, Iman Jonee Boston, MD and Cem Cengiz, MD.

CMS Open Payments shows 7 general payments to Dr. Cheema from 4 drug and device companies from 2018 to 2023. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $92.